Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy

Experimental Eye Research

Volumn 93, Issue 4, 2011, Pages 413-423

  Vogt, Susan D ^a   Curcio, Christine A ^a   Wang, Lan ^a   Li, Chuan Ming ^a   McGwin, Gerald ^a,b,d   Medeiros, Nancy E ^e   Philp, Nancy J ^f   Kimble, James A ^a,g   Read, Russell W ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Retina Specialists of North Alabama   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g Retina Specialists of Alabama   (United States)

Author keywords

Age related macular degeneration; CD46; Complement; Geographic atrophy; Histopathology; Human; Immunohistochemistry; Inflammation

Indexed keywords

EZRIN; MEMBRANE COFACTOR PROTEIN; MONOCARBOXYLATE TRANSPORTER 3;

ARTICLE; BRUCH MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GEOGRAPHIC ATROPHY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA PIGMENT DEGENERATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD46; FEMALE; GEOGRAPHIC ATROPHY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; RETINAL PIGMENT EPITHELIUM; TISSUE DONORS;

EID: 80055052597     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.06.002     Document Type: Article

References (79)

1. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
2. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited{star, open}. Prog. Retin. Eye Res. 2010, 29:95-112.
3. Bearelly S., Chau F.Y., Koreishi A., Stinnett S.S., Izatt J.A., Toth C.A. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology 2009, 116:1762-1769.
4. Bonilha V.L. Focus on molecules: ezrin. Exp. Eye Res. 2007, 84:613-614.
5. Bonilha V.L., Bhattacharya S.K., West K.A., Crabb J.S., Sun J., Rayborn M.E., Nawrot M., Saari J.C., Crabb J.W. Support for a proposed retinoid-processing protein complex in apical retinal pigment epithelium. Exp. Eye Res. 2004, 79:419-422.
6. Brar M., Kozak I., Cheng L., Bartsch D.U., Yuson R., Nigam N., Oster S.F., Mojana F., Freeman W.R. Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am. J. Ophthalmol. 2009, 148:439-444.
7. Bressler S.B., Bressler N.M., Sarks S.H., Sarks J.P. Age-related macular degeneration: nonneovascular early AMD, intermediate AMD, and geographic atrophy. Retina 2006, 1041-1074. Mosby. S.J. Ryan (Ed.).
8. Capon M.R., Marshall J., Krafft J.I., Alexander R.A., Hiscott P.S., Bird A.C. Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology 1989, 96:1769-1777.
9. Cardone J., Le Friec G., Kemper C. CD46 in innate and adaptive immunity: an update. Clin. Exp. Immunol. 2011, 164:301-311.
10. Ciulla T.A., Rosenfeld P.J. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr. Opin. Ophthalmol. 2009, 20:158-165.
11. Congdon N., O'Colmain B., Klaver C.C., Klein R., Munoz B., Friedman D.S., Kempen J., Taylor H.R., Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485.
12. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687.
13. Csaky K.G., Richman E.A., Ferris F.L. Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Invest. Ophthalmol. Vis. Sci. 2008, 49:479-489.
14. Curcio C.A., Johnson M., Huang J.-D., Rudolf M. Aging, age-related macular degeneration, and the Response-to-Retention of apolipoprotein B-containing lipoproteins. Prog. Retin. Eye Res. 2009, 28:393-422.
15. Curcio C.A., Medeiros N.E., Millican C.L. Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:1236-1249.
16. Curcio C.A., Medeiros N.E., Millican C.L. The Alabama age-related macular degeneration grading system for donor eyes. Invest. Ophthalmol. Vis. Sci. 1998, 39:1085-1096.
17. Curcio C.A., Millican C.L., Allen K.A., Kalina R.E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest. Ophthalmol. Vis. Sci. 1993, 34:3278-3296.
18. Curcio C.A., Saunders P.L., Younger P.W., Malek G. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photoreceptor loss. Ophthalmology 2000, 107:334-343.
19. Del Priore L.V., Kuo Y.H., Tezel T.H. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest. Ophthalmol. Vis. Sci. 2002, 43:3312-3318.
20. Economopoulou M., Hammer J., Wang F., Fariss R., Maminishkis A., Miller S.S. Expression, localization, and function of junctional adhesion molecule-C (JAM-C) in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2009, 50:1454-1463.
21. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
22. Fleckenstein M., Charbel Issa P., Helb H.M., Schmitz-Valckenberg S., Finger R.P., Scholl H.P., Loeffler K.U., Holz F.G. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:4137-4144.
23. Fleckenstein M., Schmitz-Valckenberg S., Adrion C., Kramer I., Eter N., Helb H.M., Brinkmann C.K., Charbel Issa P., Mansmann U., Holz F.G. Tracking progression using spectral domain optical coherence tomography in geographic atrophy due to age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2010.
24. Gallagher-Colombo S., Maminishkis A., Tate S., Grunwald G.B., Philp N.J. Modulation of MCT3 expression during wound healing of the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2010, 51:5343-5350.
25. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
26. Gouras P., Braun K., Ivert L., Neuringer M., Mattison J.A. Bestrophin detected in the basal membrane of the retinal epithelium and drusen of monkeys with drusenoid maculopathy. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247:1051-1056.
27. Green W.R., Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993, 100:1519-1535.
28. Grossniklaus H.E., Green W.R. Choroidal neovascularization. Am. J. Ophthalmol. 2004, 137:496-503.
29. Guidry C., Medeiros N.E., Curcio C.A. Phenotypic variation of retinal pigment epithelium in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2002, 43:267-273.
30. Hageman G.S. From the cover: a common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7227-7232.
31. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:705-732.
32. Hahn P. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13850-13855.
33. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
34. Hilton G.F. Subretinal pigment migration. Effects of cryosurgical retinal reattachment. Arch. Ophthalmol. 1974, 91:445-450.
35. Hogan M.J. Role of the retinal pigment epithelium in macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1972, 76:64-80.
36. Jakobsdottir J., Conley Y.P., Weeks D.E., Ferrell R.E., Gorin M.B. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS ONE 2008, 3:e2199.
37. Johnson L.V., Leitner W.P., Staples M.K., Anderson D.H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res. 2001, 73:887-896.
38. Jonas J.B., Nguyen X.N., Gusek G.C., Naumann G.O.H. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest. Ophthalmol. Vis. Sci. 1989, 30:908-918.
39. Kaneko H., Dridi S., Tarallo V., Gelfand B.D., Fowler B.J., Cho W.G., Kleinman M.E., Ponicsan S.L., Hauswirth W.W., Chiodo V.A., Kariko K., Yoo J.W., Lee D.K., Hadziahmetovic M., Song Y., Misra S., Chaudhuri G., Buaas F.W., Braun R.E., Hinton D.R., Zhang Q., Grossniklaus H.E., Provis J.M., Madigan M.C., Milam A.H., Justice N.L., Albuquerque R.J., Blandford A.D., Bogdanovich S., Hirano Y., Witta J., Fuchs E., Littman D.R., Ambati B.K., Rudin C.M., Chong M.M., Provost P., Kugel J.F., Goodrich J.A., Dunaief J.L., Baffi J.Z., Ambati J. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011, 471:325-330.
40. Kivela T., Jaaskelainen J., Vaheri A., Carpen O. Ezrin, a membrane-organizing protein, as a polarization marker of the retinal pigment epithelium in vertebrates. Cell Tissue Res. 2000, 301:217-223.
41. Klein M.L., Ferris F.L., Armstrong J., Hwang T.S., Chew E.Y., Bressler S.B., Chandra S.R. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 2008, 115:1026-1031.
42. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
43. Kuntz C.A., Jacobson S.G., Cideciyan A.V., Li Z.Y., Stone E.M., Possin D., Milam A.H. Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:1772-1782.
44. Longbottom R., Fruttiger M., Douglas R.H., Martinez-Barbera J.P., Greenwood J., Moss S.E. Genetic ablation of retinal pigment epithelial cells reveals the adaptive response of the epithelium and impact on photoreceptors. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18728-18733.
45. Lopez P.F., Yan Q., Kohen L., Rao N.A., Spee C., Black J., Oganesian A. Retinal pigment epithelial wound healing in vivo. Arch. Ophthalmol. 1995, 113:1437-1446.
46. Maller J.B., Fagerness J.A., Reynolds R.C., Neale B.M., Daly M.J., Seddon J.M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 2007, 39:1200-1201.
47. McKay G.J., Silvestri G., Patterson C.C., Hogg R.E., Chakravarthy U., Hughes A.E. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:533-539.
48. McLaughlin B.J., Fan W., Zheng J.J., Cai H., Del Priore L.V., Bora N.S., Kaplan H.J. Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion. Invest. Ophthalmol. Vis. Sci. 2003, 44:3669-3674.
49. McLeod D.S., Grebe R., Bhutto I., Merges C., Baba T., Lutty G.A. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:4982-4991.
50. Meleth A.D., Wong W.T., Chew E.Y. Treatment for atrophic macular degeneration. Curr. Opin. Ophthalmol. 2011, 22:190-193.
51. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000, 14:835-846.
52. Philp N.J., Wang D., Yoon H., Hjelmeland L.M. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:1716-1721.
53. Philp N.J., Yoon H., Lombardi L. Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. Am. J. Physiol., Cell Physiol. 2001, 280:C1319-C1326.
54. Rich R.M., Rosenfeld P.J., Puliafito C.A., Dubovy S.R., Davis J.L., Flynn H.W., Gonzalez S., Feuer W.J., Lin R.C., Lalwani G.A., Nguyen J.K., Kumar G. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006, 26:495-511.
55. Ripps H. Night blindness revisited: from man to molecules. Proctor lecture. Invest. Ophthalmol. Vis. Sci. 1982, 23:588-609.
56. Roquet W., Roudot-Thoraval F., Coscas G., Soubrane G. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br. J. Ophthalmol. 2004, 88:638-642.
57. Sarks J.P., Sarks S.H., Killingsworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988, 2(Pt 5):552-577.
58. Sarks S., Cherepanoff S., Killingsworth M., Sarks J. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2007, 48:968-977.
59. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
60. Shi G., Maminishkis A., Banzon T., Jalickee S., Li R., Hammer J., Miller S.S. Control of chemokine gradients by the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2008, 49:4620-4630.
61. Sonoda S., Sreekumar P.G., Kase S., Spee C., Ryan S.J., Kannan R., Hinton D.R. Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration. Aging (Albany NY) 2010, 2:28-42.
62. Spaide R.F., Armstrong D., Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause?. Retina 2003, 23:595-614.
63. Spraul C.W., Grossniklaus H.E. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch. Ophthalmol. 1997, 115:267-273.
64. Steinberg R.H., Wood I., Hogan M.J. Pigment epithelial ensheathment and phagocytosis of extrafoveal cones in human retina. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 1977, 277:459-474.
65. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85:845-881.
66. Sunness J.S., Applegate C.A., Bressler N.M., Hawkins B.S. Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study. Retina 2007, 27:204-210.
67. Sunness J.S., Margalit E., Srikumaran D., Applegate C.A., Tian Y., Perry D., Hawkins B.S., Bressler N.M. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 2007, 114:271-277.
68. Tanos B., Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008, 27:6939-6957.
69. van der Schaft T.L., Mooy C.M., de Bruijn W.C., Oron F.G., Mulder P.G., de Jong P.T. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology 1992, 99:278-286.
70. Vogt S.D., Barnum S.R., Curcio C.A., Read R.W. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp. Eye Res. 2006, 83:834-840.
71. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
72. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
73. Wang F.E., Zhang C., Maminishkis A., Dong L., Zhi C., Li R., Zhao J., Majerciak V., Gaur A.B., Chen S., Miller S.S. MicroRNA-204/211 alters epithelial physiology. FASEB J. 2010, 24:1552-1571.
74. Wang L., Clark M.E., Crossman D.K., Kojima K., Messinger J.D., Mobley J.A., Curcio C.A. Abundant lipid and protein components of drusen. PLoS ONE 2010, 5:e10329.
75. Wang L., Tornquist P., Bill A. Glucose metabolism in pig outer retina in light and darkness. Acta Physiol. Scand. 1997, 160:75-81.
76. Winkler B.S., Arnold M.J., Brassell M.A., Sliter D.R. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats. Invest. Ophthalmol. Vis. Sci. 1997, 38:62-71.
77. Yang P., Tyrrell J., Han I., Jaffe G.J. Expression and modulation of RPE cell membrane complement regulatory proteins. Invest. Ophthalmol. Vis. Sci. 2009, 50:3473-3481.
78. Zareparsi S., Branham K.E., Li M., Shah S., Klein R.J., Ott J., Hoh J., Abecasis G.R., Swaroop A. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 2005, 77:149-153.
79. Zhao C., Yasumura D., Li X., Matthes M., Lloyd M., Nielsen G., Ahern K., Snyder M., Bok D., Dunaief J.L., Lavail M.M., Vollrath D. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J. Clin. Invest. 2011, 121:369-383.